The Extra Corporeal Membrane Oxygenation System Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Modality (Ven-Arterial (VA), Ven-Venous (VV), Others), By Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)).
In 2024, the market for extracorporeal membrane oxygenation (ECMO) systems addresses the critical need for advanced life support technology in the management of severe respiratory and cardiac failure, offering comprehensive ECMO systems designed to provide temporary cardiopulmonary support and oxygenation to critically ill patients. ECMO is a life-saving therapy that involves the use of an extracorporeal circuit to pump blood outside the body, oxygenate it, remove carbon dioxide, and return it to the patient's circulatory system, bypassing the lungs or heart. ECMO systems consist of a console with a blood pump, membrane oxygenator, tubing set, and accessories for vascular access, anticoagulation, and gas exchange monitoring. These systems may be used in various clinical scenarios, including acute respiratory distress syndrome (ARDS), acute heart failure, post-cardiotomy shock, or refractory cardiogenic shock, providing temporary circulatory and/or respiratory support while allowing time for organ recovery or definitive treatment. With a focus on patient safety, hemodynamic stability, and treatment efficacy, ECMO systems undergo rigorous testing, quality control, and regulatory approval processes to ensure their safety, reliability, and performance in critical care settings. Moreover, with advancements in device miniaturization, circuit design, and monitoring technology, the ECMO market continues to innovate, offering portable ECMO systems, integrated monitoring solutions, and patient-specific treatment algorithms for optimizing outcomes, reducing complications, and improving survival rates in patients with severe respiratory or cardiac failure.
A prominent trend in the Extra Corporeal Membrane Oxygenation (ECMO) system market is the expansion of ECMO therapy beyond traditional indications. Originally developed for use in acute respiratory failure and cardiac support, ECMO therapy is increasingly being explored and utilized in a broader range of clinical scenarios. This includes applications such as cardiopulmonary resuscitation (CPR), extracorporeal cardiopulmonary resuscitation (ECPR), organ transplantation, septic shock, and acute exacerbations of chronic lung disease. The versatility and effectiveness of ECMO therapy in providing temporary life support and organ recovery have led to its adoption in novel clinical contexts, driving market growth and innovation in ECMO system design, technology, and application.
A key driver for the ECMO system market is the increasing prevalence of severe respiratory and cardiac conditions worldwide. Respiratory failure, acute respiratory distress syndrome (ARDS), cardiogenic shock, and other life-threatening cardiac and pulmonary disorders contribute to a significant burden of morbidity and mortality globally. ECMO therapy serves as a vital treatment option for patients with refractory respiratory or cardiac failure, providing temporary mechanical support to the heart and lungs while allowing time for recovery or transplantation. The rising incidence of these conditions, driven by factors such as the aging population, chronic diseases, and infectious outbreaks, fuels demand for ECMO systems as essential tools in critical care and emergency medicine, supporting market growth and investment in ECMO technology.
An opportunity for innovation and market expansion in the ECMO system market lies in the development of portable and mobile ECMO systems. Traditional ECMO systems are often large, complex, and confined to specialized intensive care units (ICUs) or operating rooms. However, there is growing interest and demand for ECMO systems that are portable, lightweight, and suitable for use in transport settings such as ambulances, helicopters, and remote healthcare facilities. Portable ECMO systems enable early initiation of ECMO therapy in the prehospital setting, facilitating rapid stabilization and transport of critically ill patients to tertiary care centers or ECMO-capable hospitals. Additionally, mobile ECMO systems provide flexibility and versatility in delivering ECMO therapy outside the traditional hospital environment, such as during mass casualty incidents, disaster response efforts, or medical evacuations. By developing innovative ECMO systems optimized for mobility, companies can address unmet clinical needs, improve patient outcomes, and capture new opportunities in the expanding market for portable and mobile ECMO technology.
In the Extra Corporeal Membrane Oxygenation (ECMO) System Market, the Ven-Arterial (VA) modality is the fastest-growing segment. This growth is driven by its application in both respiratory and cardiac support. VA-ECMO systems are highly effective in providing oxygenation and circulatory support to patients experiencing severe respiratory or cardiac failure. Their ability to support both heart and lung function makes them versatile and widely used in critical care settings. The increasing prevalence of respiratory and cardiac diseases, coupled with advancements in ECMO technology improving patient outcomes, is fueling the demand for VA-ECMO systems. As a result, this segment is expected to experience significant growth in the ECMO market.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAbbott Laboratories, Eurosets S.r.l., Fresenius Medical Care AG & Co. KGaA, Getinge AB, Inspira Technologies LLC, LivaNova PLC, Medtronic plc, MicroPort Scientific Corp, Terumo Medical Corp
By Modality
Ven-Arterial (VA)
Ven-Venous (VV)
Others
By Application
Respiratory
Cardiac
Extracorporeal Cardiopulmonary Resuscitation (ECPR)
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott Laboratories
Eurosets S.r.l.
Fresenius Medical Care AG & Co. KGaA
Getinge AB
Inspira Technologies LLC
LivaNova PLC
Medtronic plc
MicroPort Scientific Corp
Terumo Medical Corp
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Extra Corporeal Membrane Oxygenation System Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Extra Corporeal Membrane Oxygenation System Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Extra Corporeal Membrane Oxygenation System Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Extra Corporeal Membrane Oxygenation System Market Size Outlook, $ Million, 2021 to 2030
3.2 Extra Corporeal Membrane Oxygenation System Market Outlook by Type, $ Million, 2021 to 2030
3.3 Extra Corporeal Membrane Oxygenation System Market Outlook by Product, $ Million, 2021 to 2030
3.4 Extra Corporeal Membrane Oxygenation System Market Outlook by Application, $ Million, 2021 to 2030
3.5 Extra Corporeal Membrane Oxygenation System Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Extra Corporeal Membrane Oxygenation System Industry
4.2 Key Market Trends in Extra Corporeal Membrane Oxygenation System Industry
4.3 Potential Opportunities in Extra Corporeal Membrane Oxygenation System Industry
4.4 Key Challenges in Extra Corporeal Membrane Oxygenation System Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Extra Corporeal Membrane Oxygenation System Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Extra Corporeal Membrane Oxygenation System Market Outlook by Segments
7.1 Extra Corporeal Membrane Oxygenation System Market Outlook by Segments, $ Million, 2021- 2030
By Modality
Ven-Arterial (VA)
Ven-Venous (VV)
Others
By Application
Respiratory
Cardiac
Extracorporeal Cardiopulmonary Resuscitation (ECPR)
8 North America Extra Corporeal Membrane Oxygenation System Market Analysis and Outlook To 2030
8.1 Introduction to North America Extra Corporeal Membrane Oxygenation System Markets in 2024
8.2 North America Extra Corporeal Membrane Oxygenation System Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Extra Corporeal Membrane Oxygenation System Market size Outlook by Segments, 2021-2030
By Modality
Ven-Arterial (VA)
Ven-Venous (VV)
Others
By Application
Respiratory
Cardiac
Extracorporeal Cardiopulmonary Resuscitation (ECPR)
9 Europe Extra Corporeal Membrane Oxygenation System Market Analysis and Outlook To 2030
9.1 Introduction to Europe Extra Corporeal Membrane Oxygenation System Markets in 2024
9.2 Europe Extra Corporeal Membrane Oxygenation System Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Extra Corporeal Membrane Oxygenation System Market Size Outlook by Segments, 2021-2030
By Modality
Ven-Arterial (VA)
Ven-Venous (VV)
Others
By Application
Respiratory
Cardiac
Extracorporeal Cardiopulmonary Resuscitation (ECPR)
10 Asia Pacific Extra Corporeal Membrane Oxygenation System Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Extra Corporeal Membrane Oxygenation System Markets in 2024
10.2 Asia Pacific Extra Corporeal Membrane Oxygenation System Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Extra Corporeal Membrane Oxygenation System Market size Outlook by Segments, 2021-2030
By Modality
Ven-Arterial (VA)
Ven-Venous (VV)
Others
By Application
Respiratory
Cardiac
Extracorporeal Cardiopulmonary Resuscitation (ECPR)
11 South America Extra Corporeal Membrane Oxygenation System Market Analysis and Outlook To 2030
11.1 Introduction to South America Extra Corporeal Membrane Oxygenation System Markets in 2024
11.2 South America Extra Corporeal Membrane Oxygenation System Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Extra Corporeal Membrane Oxygenation System Market size Outlook by Segments, 2021-2030
By Modality
Ven-Arterial (VA)
Ven-Venous (VV)
Others
By Application
Respiratory
Cardiac
Extracorporeal Cardiopulmonary Resuscitation (ECPR)
12 Middle East and Africa Extra Corporeal Membrane Oxygenation System Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Extra Corporeal Membrane Oxygenation System Markets in 2024
12.2 Middle East and Africa Extra Corporeal Membrane Oxygenation System Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Extra Corporeal Membrane Oxygenation System Market size Outlook by Segments, 2021-2030
By Modality
Ven-Arterial (VA)
Ven-Venous (VV)
Others
By Application
Respiratory
Cardiac
Extracorporeal Cardiopulmonary Resuscitation (ECPR)
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Eurosets S.r.l.
Fresenius Medical Care AG & Co. KGaA
Getinge AB
Inspira Technologies LLC
LivaNova PLC
Medtronic plc
MicroPort Scientific Corp
Terumo Medical Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Modality
Ven-Arterial (VA)
Ven-Venous (VV)
Others
By Application
Respiratory
Cardiac
Extracorporeal Cardiopulmonary Resuscitation (ECPR)
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Extra Corporeal Membrane Oxygenation System Market is one of the lucrative growth markets, poised to register a 5.1% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott Laboratories, Eurosets S.r.l., Fresenius Medical Care AG & Co. KGaA, Getinge AB, Inspira Technologies LLC, LivaNova PLC, Medtronic plc, MicroPort Scientific Corp, Terumo Medical Corp
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume